Geron Corp (GERN)

Geron is a biopharmaceutical company that makes drugs to treat cancer, spinal-cord injuries, heart failure, and diabetes. They're based in Menlo Park, California.

Show Chart

Events

  • June 72012
    Geron Corporation Presents at Jefferies 2012 Global Healthcare Conference, Jun-07-2012 01:30 PM
  • August 12012
    Geron Corporation expected to report Q2 2012 results on August 1, 2012. This event was calculated by Capital IQ (Created on May 5, 2012).
  • February242013
    Geron Corporation expected to report Fiscal Year 2012 results on February 24, 2013. This event was calculated by Capital IQ (Created on March 9, 2012).

Members who own this company also own

Current price per share


Today's gain: $0.02 (1.40%)

Is this a fair price given publicly available information?
(Not an indicator of whether the price will go up or down.)
Close Icon